Literature DB >> 30879355

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Donna K Arnett, Roger S Blumenthal, Michelle A Albert1, Andrew B Buroker2, Zachary D Goldberger3, Ellen J Hahn1, Cheryl Dennison Himmelfarb1, Amit Khera1, Donald Lloyd-Jones1, J William McEvoy1, Erin D Michos1, Michael D Miedema1, Daniel Muñoz1, Sidney C Smith1, Salim S Virani1, Kim A Williams1, Joseph Yeboah1, Boback Ziaeian4.   

Abstract

Entities:  

Keywords:  AHA Scientific Statements; LDL cholesterol; antihypertensive agents; aspirin; atherosclerosis; atherosclerotic cardiovascular disease; atrial fibrillation; behavior modification; behavior therapy; blood cholesterol; blood pressure; body mass index; cardiovascular; cardiovascular disease; cardiovascular team-based care; cholesterol; chronic kidney disease; coronary artery calcium score; coronary disease; coronary heart disease; cost; diabetes mellitus; diet; dietary fats; dietary patterns; dietary sodium; dyslipidemia; e-cigarettes; exercise; guidelines; health services accessibility; healthcare disparities; heart failure; hypertension; lifestyle; lipids; measurement; myocardial infarction; nicotine; nonpharmacological treatment; nutrition; physical activity; prejudice; primary prevention; psychosocial deprivation; public health; quality indicators; quality measurement; risk assessment; risk factors; risk reduction; risk reduction discussion; risk treatment discussion; risk-enhancing factors; secondhand smoke; sleep; smoking; smoking cessation; social determinants of health; socioeconomic factors; statin therapy; systems of care; tobacco; tobacco smoke pollution; treatment adherence; treatment outcomes; type 2 diabetes mellitus; waist circumference; weight loss

Mesh：

Year:  2019        PMID： 30879355      PMCID： PMC7734661          DOI： 10.1161/CIR.0000000000000678

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  407 in total

Review 1.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies.

Authors: 
Journal:  Lancet       Date:  2004-01-10       Impact factor: 79.321

Review 2.  Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels--overview and meta-analyses of randomized trials.

Authors:  Costas Thomopoulos; Gianfranco Parati; Alberto Zanchetti
Journal:  J Hypertens       Date:  2014-12       Impact factor: 4.844

3.  Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United States.

Authors:  Michelle C Odden; Mark J Pletcher; Pamela G Coxson; Divya Thekkethala; David Guzman; David Heller; Lee Goldman; Kirsten Bibbins-Domingo
Journal:  Ann Intern Med       Date:  2015-04-21       Impact factor: 25.391

4.  Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).

Authors:  Peter S Sever; Neil R Poulter; Björn Dahlöf; Hans Wedel; Rory Collins; Gareth Beevers; Mark Caulfield; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

5.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

6.  Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial.

Authors:  Jan D Hirsch; Neil Steers; David S Adler; Grace M Kuo; Candis M Morello; Megan Lang; Renu F Singh; Yelena Wood; Robert M Kaplan; Carol M Mangione
Journal:  Clin Ther       Date:  2014-07-30       Impact factor: 3.393

7.  Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials.

Authors:  J M Geleijnse; F J Kok; D E Grobbee
Journal:  J Hum Hypertens       Date:  2003-07       Impact factor: 3.012

8.  Cost-Effectiveness of a Physician-Pharmacist Collaboration Intervention to Improve Blood Pressure Control.

Authors:  Linnea A Polgreen; Jayoung Han; Barry L Carter; Gail P Ardery; Christopher S Coffey; Elizabeth A Chrischilles; Paul A James
Journal:  Hypertension       Date:  2015-11-02       Impact factor: 10.190

9.  Implications of the US cholesterol guidelines on eligibility for statin therapy in the community: comparison of observed and predicted risks in the Framingham Heart Study Offspring Cohort.

Authors:  Charlotte Andersson; Danielle Enserro; Martin G Larson; Vanessa Xanthakis; Ramachandran S Vasan
Journal:  J Am Heart Assoc       Date:  2015-04-17       Impact factor: 5.501

10.  Heart Disease and Cancer Deaths - Trends and Projections in the United States, 1969-2020.

Authors:  Hannah K Weir; Robert N Anderson; Sallyann M Coleman King; Ashwini Soman; Trevor D Thompson; Yuling Hong; Bjorn Moller; Steven Leadbetter
Journal:  Prev Chronic Dis       Date:  2016-11-17       Impact factor: 2.830
View more
  678 in total

1.  Antihypertensive medications and physical function in older persons.

Authors:  Carlos A Vaz Fragoso; Gail J McAvay
Journal:  Exp Gerontol       Date:  2020-06-25       Impact factor: 4.032

Review 2.  Industry Funding and Cholesterol Research: A Systematic Review.

Authors:  Neal D Barnard; M Blaire Long; Jennifer M Ferguson; Rosendo Flores; Hana Kahleova
Journal:  Am J Lifestyle Med       Date:  2019-12-11

3.  Polypill for Cardiovascular Disease Prevention in an Underserved Population. Reply.

Authors:  Thomas J Wang; Daniel Muñoz; William J Blot
Journal:  N Engl J Med       Date:  2020-01-02       Impact factor: 91.245

Review 4.  Metabolomic Biomarkers of Healthy Dietary Patterns and Cardiovascular Outcomes.

Authors:  Hyunju Kim; Casey M Rebholz
Journal:  Curr Atheroscler Rep       Date:  2021-03-30       Impact factor: 5.113

Review 5.  The Use of Sex-Specific Factors in the Assessment of Women's Cardiovascular Risk.

Authors:  Anandita Agarwala; Erin D Michos; Zainab Samad; Christie M Ballantyne; Salim S Virani
Journal:  Circulation       Date:  2020-02-17       Impact factor: 29.690

Review 6.  Optimizing Dyslipidemia Management for the Prevention of Cardiovascular Disease: a Focus on Risk Assessment and Therapeutic Options.

Authors:  Adam N Berman; Ron Blankstein
Journal:  Curr Cardiol Rep       Date:  2019-08-05       Impact factor: 2.931

Review 7.  Cardiovascular disease in patients with severe mental illness.

Authors:  René Ernst Nielsen; Jytte Banner; Svend Eggert Jensen
Journal:  Nat Rev Cardiol       Date:  2020-10-30       Impact factor: 32.419

8.  Association of Normal Systolic Blood Pressure Level With Cardiovascular Disease in the Absence of Risk Factors.

Authors:  Seamus P Whelton; John W McEvoy; Leslee Shaw; Bruce M Psaty; Joao A C Lima; Matthew Budoff; Khurram Nasir; Moyses Szklo; Roger S Blumenthal; Michael J Blaha
Journal:  JAMA Cardiol       Date:  2020-09-01       Impact factor: 14.676

Review 9.  Aspirin in primary prevention: the triumph of clinical judgement over complex equations.

Authors:  Francesca Santilli; Paola Simeone
Journal:  Intern Emerg Med       Date:  2019-09-21       Impact factor: 3.397

Review 10.  Aspirin for Primary Prevention of Cardiovascular Disease in Diabetes: a Review of the Evidence.

Authors:  Mohammed E Al-Sofiani; Robert Derenbecker; Michael Quartuccio; Rita R Kalyani
Journal:  Curr Diab Rep       Date:  2019-09-23       Impact factor: 4.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.